Welcome!

News Feed Item

Technology and Biotech Companies Poised for a Big 2018

LAS VEGAS, February 15, 2018 /PRNewswire/ --

FN Media Group Presents Microcapspeculators.com News Commentary 

Advancements in technology are happening rapidly, continuously changing industries across the medical world. Technological inventions are especially fueling innovation in the biotechnology sector. Biotech companies are gaining new knowledge in technology and implementing this knowledge in order to push new drugs and therapies to the market. Included in today's commentary:Endonovo Therapeutics, Inc. (OTC: ENDV), Neurometrix, Inc. (NASDAQ: NURO), Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE), Bitcoin Investment Trust. (OTC: GBTC), and Helios and Matheson Analytics Inc. (NASDAQ: HMNY).

The drug market is facing a huge battle against opioids and biotechnology companies are leaning more toward the use of technology in treating pain. The opioid epidemic has created a dire need for non-pharmacological alternatives for pain relief and many companies are working hard to make this a reality. Drug overdose deaths exceeded 59,000 in 2017, according to the New York Times, and are now the leading cause of death among Americans under 50. This epidemic has led to medical innovations that seek to relieve pain with technology and without the use of highly addictive drugs.

Most of these technologies work by sending electrical signals through the nerves in order to block the pain. Many medical devices using electrical stimulation, such as implantable Spinal Cord Stimulators or non-invasive Transcutaneous Electrical Nerve Stimulators (TENS), block pain by stimulating the nerves. Newer therapies are targeting inflammation instead of nerve-blocking.

Biotech and technology companies are working around the clock to put out a method that works in order to put a halt to the opioid crisis as well as offer effective and efficient pain relief therapies for a diverse set of patients. Additionally, the newly popular blockchain technologies could create an avenue to share and store information across sector the technology and biotech sectors regarding what therapies are working to combat the opioid crisis, and what isn't.

A few companies to look into that are changing both the future of technology and biotechnology alike include: Endonovo Therapeutics, Inc. (OTCQB: ENDV), Neurometrix, Inc. (NASDAQ: NURO), Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE), Bitcoin Investment Trust. (OTCQX: GBTC), and Helios and Matheson Analytics Inc. (NASDAQ: HMNY).

Endonovo Therapeutics, Inc. (OTCQB: ENDV)

Market Cap: $11.6M, current share price: $.038 

With the start of commercial sales of its non-invasive medical device, SofPulse™, for the palliative treatment of pain and post-surgical edema last month and an announced senior secured redeemable Series C Preferred Stock offering, Endonovo Therapeutics, Inc. (ENDV), a commercial stage developer of non-invasive Electroceuticals, has all the pieces in place for a successful launch of its cutting-edge therapy into the pain relief therapeutics market expected to reach $83 billion by 2024, according to Transparency Market Research. Endonovo's therapy works by treating the underlying cause of the pain itself: inflammation. Additionally, unlike other medical device companies that obtain FDA Clearance, Endonovo has reimbursement from Medicare for the treatment of chronic wounds, which places it advantageously to actually generate revenue from its products. Other companies with similar technologies have= failed to achieve the same clinical results as Endonovo's SofPulse™ in clinical trials for reducing pain following breast augmentation surgery. With positive clinical data in the treatment of ischemic cardiomyopathy in patients with failed medical therapy and revascularization options, ENDV is severely undervalued compared to its competitors, which are worth $250 to $320 million in market cap despite having smaller clinical pipelines with less than stellar clinical data and not having commercial stage products.

Neurometrix, Inc. (NASDAQ: NURO) 

Market Cap: $9.427M, current share price: $1.32 

NURO is a commercial stage, innovation driven healthcare company combining neurostimulation and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company's lead product is Quell, an over-the-counter wearable therapeutic device for chronic pain. In early Q1 2018 the Company reported a strategic collaboration with GlaxoSmithKline (GSK) under which GSK Consumer Healthcare acquired Quell market rights outside the US while NeuroMetrix retained ownership for the US market. The companies will co-fund Quell technology development. GSK Consumer Healthcare paid $5 million for the Quell assets related to markets outside the US and will pay up to $21.5 million upon the achievement of certain development and commercialization milestones. Like ENDV's platform, Quell focuses on relieving pain. This technology has the potential to improve reduce the dependency on opioids.

Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE) 

Market Cap: $155.79, current share price: $11.49

Zynerba Pharmaceuticals Inc. is a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically-produced transdermal cannabinoid treatments for rare or near-rare neuropsychiatric diseases with high unmet medical needs.  ZYNE is down over 50% from it's highs throughout the last year.  This company like ENDV is doing some very exciting things and should be on everyone's watchlist.  

Bitcoin Investment Trust. (OTCQB: GBTC) 

Market Cap: $2.53B, current share price: $16.44 

GBTC is the first publicly bitcoin price based security.  The company is being pitched as the best way to invest into bitcoin without having to worry about how to make sure your coins are actually safe.  GBTC is up over 1400% from where it was priced just a year ago, keep an eye out for this stock should bitcoin continue to increase in price.  

Helios and Matheson Analytics Inc. (NASDAQ: HMNY)  

Market Cap: $120.839M, current share price: $5.04 

HMNY is a provider of information technology services and solutions, offering a range of technology platforms focusing on big data, artificial intelligence, business intelligence, social listening, and consumer-centric technology. HMNY owns a majority interest in MoviePass Inc., the nation's premier movie-theater subscription service. HMNY's holdings include RedZone Map™, a safety and navigation app for iOS and Android users, and a community-based ecosystem that features a socially empowered safety map app that enhances mobile GPS navigation using advanced proprietary technology.

For Full Legal Disclaimer Click Here.

DISCLAIMER: Microcapspeculators.com (MS) is the source of the content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM,) and its online brand FinancialNewsMedia.com, is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with MS or any company mentioned herein. The commentary, views and opinions expressed in this release by MS are solely those of MS and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable MS and FNM for any investment decisions by their readers or subscribers. MS and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks included herein by MS. FNM was not compensated by any public company mentioned herein to disseminate this press release on behalf of MS.

MS Disclosure:  Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC. which owns Microcapspeculators.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC. which owns, Microcapspeculators.com may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC. which owns Microcapspeculators.com may be compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.  The forward-looking statements in this release are made as of the date hereof and MS and FNM undertake no obligation to update such statements.

Website: http://microcapspeculators.com/

Content Provided By: Microcap Speculators
Email: [email protected]
Phone: +1-702-720-6310


Media Contact
FN Media Group LLC
e-mail: [email protected]
+1(954)345-0611

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Headquartered in Plainsboro, NJ, Synametrics Technologies has provided IT professionals and computer systems developers since 1997. Based on the success of their initial product offerings (WinSQL and DeltaCopy), the company continues to create and hone innovative products that help its customers get more from their computer applications, databases and infrastructure. To date, over one million users around the world have chosen Synametrics solutions to help power their accelerated business or per...
DXWorldEXPO LLC announced today that the upcoming DXWorldEXPO | DevOpsSUMMIT | CloudEXPO New York will feature 10 companies from Poland to participate at the "Poland Digital Transformation Pavilion" on November 12-13, 2018. Polish Digital Transformation companies which will exhibit at CloudEXPO | DevOpsSUMMIT | DXWorldEXPO include All in Mobile, dhosting, Cryptomage, Perfect Gym, Polcom, Apius Technologies, Aplisens, ELZAB SA, TELDAT, and Rebug.io.
Authorization of web applications developed in the cloud is a fundamental problem for security, yet companies often build solutions from scratch, which is error prone and impedes time to market. This talk shows developers how they can (instead) build on-top of community-owned projects and frameworks for better security.Whether you build software for enterprises, mobile, or internal microservices, security is important. Standards like SAML, OIDC, and SPIFFE help you solve identity and authenticat...
The digital transformation is real! To adapt, IT professionals need to transform their own skillset to become more multi-dimensional by gaining both depth and breadth of a wide variety of knowledge and competencies. Historically, while IT has been built on a foundation of specialty (or "I" shaped) silos, the DevOps principle of "shifting left" is opening up opportunities for developers, operational staff, security and others to grow their skills portfolio, advance their careers and become "T"-sh...
This session will provide an introduction to Cloud driven quality and transformation and highlight the key features that comprise it. A perspective on the cloud transformation lifecycle, transformation levers, and transformation framework will be shared. At Cognizant, we have developed a transformation strategy to enable the migration of business critical workloads to cloud environments. The strategy encompasses a set of transformation levers across the cloud transformation lifecycle to enhance ...
Digital Transformation and Disruption, Amazon Style - What You Can Learn. Chris Kocher is a co-founder of Grey Heron, a management and strategic marketing consulting firm. He has 25+ years in both strategic and hands-on operating experience helping executives and investors build revenues and shareholder value. He has consulted with over 130 companies on innovating with new business models, product strategies and monetization. Chris has held management positions at HP and Symantec in addition to ...
Lori MacVittie is a subject matter expert on emerging technology responsible for outbound evangelism across F5's entire product suite. MacVittie has extensive development and technical architecture experience in both high-tech and enterprise organizations, in addition to network and systems administration expertise. Prior to joining F5, MacVittie was an award-winning technology editor at Network Computing Magazine where she evaluated and tested application-focused technologies including app secu...
Dynatrace is an application performance management software company with products for the information technology departments and digital business owners of medium and large businesses. Building the Future of Monitoring with Artificial Intelligence. Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more busine...
Having been in the web hosting industry since 2002, dhosting has gained a great deal of experience while working on a wide range of projects. This experience has enabled the company to develop our amazing new product, which they are now excited to present! Among dHosting's greatest achievements, they can include the development of their own hosting panel, the building of their fully redundant server system, and the creation of dhHosting's unique product, Dynamic Edge.
Your job is mostly boring. Many of the IT operations tasks you perform on a day-to-day basis are repetitive and dull. Utilizing automation can improve your work life, automating away the drudgery and embracing the passion for technology that got you started in the first place. In this presentation, I'll talk about what automation is, and how to approach implementing it in the context of IT Operations. Ned will discuss keys to success in the long term and include practical real-world examples. Ge...
The challenges of aggregating data from consumer-oriented devices, such as wearable technologies and smart thermostats, are fairly well-understood. However, there are a new set of challenges for IoT devices that generate megabytes or gigabytes of data per second. Certainly, the infrastructure will have to change, as those volumes of data will likely overwhelm the available bandwidth for aggregating the data into a central repository. Ochandarena discusses a whole new way to think about your next...
So the dumpster is on fire. Again. The site's down. Your boss's face is an ever-deepening purple. And you begin debating whether you should join the #incident channel or call an ambulance to deal with his impending stroke. Yes, we know this is a developer's fault. There's plenty of time for blame later. Postmortems have a macabre name because they were once intended to be Viking-like funerals for someone's job. But we're civilized now. Sort of. So we call them post-incident reviews. Fires are ne...
CloudEXPO New York 2018, colocated with DevOpsSUMMIT and DXWorldEXPO New York 2018 will be held November 12-13, 2018, in New York City and will bring together Cloud Computing, FinTech and Blockchain, Digital Transformation, Big Data, Internet of Things, DevOps, AI and Machine Learning to one location.
CloudEXPO | DevOpsSUMMIT | DXWorldEXPO are the world's most influential, independent events where Cloud Computing was coined and where technology buyers and vendors meet to experience and discuss the big picture of Digital Transformation and all of the strategies, tactics, and tools they need to realize their goals. Sponsors of DXWorldEXPO | CloudEXPO benefit from unmatched branding, profile building and lead generation opportunities.
ICC is a computer systems integrator and server manufacturing company focused on developing products and product appliances to meet a wide range of computational needs for many industries. Their solutions provide benefits across many environments, such as datacenter deployment, HPC, workstations, storage networks and standalone server installations. ICC has been in business for over 23 years and their phenomenal range of clients include multinational corporations, universities, and small busines...